CION Ameerpet
Pancreatic Cancer · Treatment & Modalities · Reviewed by CION Oncologists
Chemotherapy before pancreatic surgery — what neoadjuvant treatment and downstaging really mean
Being told that chemotherapy comes before the operation can sound like a delay, or like bad news. It is usually neither. Treating first is now the deliberate opening move for tumours sitting against the vessels behind the pancreas — and it is how a surgeon finds out whether the operation is worth its risks.
- Treating first is a strategy, not a postponement — the operation question stays open, and is asked again on a fresh scan.
- Downstaging is judged on more than the scan — vessel contact, the CA 19-9 trend, no new disease, and whether you are fit enough.
- Chemotherapy is delivered in-house at CION — the operation itself is coordinated with partner hepatobiliary surgeons.
- Progression during treatment is information — a cancer that shows itself early spares you an operation that could not have worked.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres Across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
Why Treatment Is Being Given Before the Operation
If the plan you have been given is chemotherapy first, it can sound as though surgery has quietly been taken off the table. Usually it has not. Neoadjuvant simply means treatment given before an operation, and for pancreatic cancer it is now a deliberate opening move rather than a fallback — especially when the tumour is sitting against the arteries and veins that run behind the pancreas.
Most people who search for neoadjuvant chemotherapy pancreatic cancer are really asking two things: why the order was changed, and whether the operation will still happen. This page answers both, and explains what a doctor means by downstaging, which is a word used far more often than it is defined.
Three things are being attempted at the same time. The first is local. Treatment can shrink the tumour, or at least loosen its grip on a vessel, so that a surgeon has a realistic chance of removing all of it with a clear margin rather than leaving disease behind. The second is systemic. Pancreatic cancer sheds cells early, and treating the whole body first deals with deposits too small for any scan to show — the deposits that otherwise bring the cancer back a few months after an apparently successful operation.
The third reason is the one rarely said out loud, and it is worth saying. Time is information. A few months of treatment shows how this particular cancer behaves. If it holds still or retreats, an operation is far more likely to be worth its considerable risks. If it spreads during those months, that operation would not have cured it, and you have been spared a very large procedure and a long recovery for nothing.
The order is not a verdict on how bad your cancer is. Chemotherapy’s role in pancreatic cancer covers where systemic treatment sits across every stage, and how the intensity is chosen. This page stays with the before-surgery question, and with borderline resectable pancreatic cancer, which is where treating first is most often recommended.
Did you know? NCCN guidance on pancreatic adenocarcinoma names systemic therapy before surgery as the preferred first step for borderline resectable disease, and as an accepted option for anatomically removable tumours that carry high-risk features — a markedly raised CA 19-9, suspicious regional lymph nodes, or significant weight loss and pain. The same guidance carries a caution most patients are never told: a scan taken after neoadjuvant treatment tends to overstate how much tumour is left, because treated tissue and scar tissue look much like living tumour on CT. That is why the decision to operate is made on the whole picture — imaging, marker trend, symptoms and fitness together — and never on one scan report read on its own.
It depends where you are
What Treating First Is Aiming At, by Category
The resectability category — not the stage number — is what decides the order. Find your row, and read the last column carefully.
| Category | What the scan shows | What treating first is aiming at | Where the operation question sits |
|---|---|---|---|
| Resectable | The tumour is clear of the major arteries, and touches a vein little or not at all. | Treating unseen disease early, and watching how the cancer behaves before committing to a long operation. | Often first, with chemotherapy afterwards. The Whipple procedure — what to expect sets out that operation in full. |
| Resectable, high-risk features | Removable on anatomy alone, but with a markedly raised CA 19-9, suspicious nodes or heavy weight loss. | Testing how the cancer behaves before surgery, so that disease already on the move is not treated as a local problem. | Reopened after treatment, once the marker trend and a fresh scan are both available. |
| Borderline resectable | Contact with a vein that could be reconstructed, or limited contact with an artery. | Loosening the tumour off the vessel and clearing the margin, so the whole tumour comes out rather than most of it. | Genuinely open, and asked again after treatment. Borderline resectable pancreatic cancer explains the categories. |
| Locally advanced | The tumour wraps an artery and cannot be removed as things stand. | Control first. Some tumours retreat far enough to become operable; many do not, and treatment continues as the main plan. | Asked again after several months, sometimes after chemoradiation or SBRT has been added. |
Pancreatic neuroendocrine tumours are not treated on this pathway at all. They grow differently, respond to different systemic treatment, and the surgical decision is made on its own terms. If your pathology report says neuroendocrine tumour, this page does not describe your plan — check the wording on the report itself rather than how the diagnosis was summarised in conversation.
The word, defined
What Downstaging Actually Means, and How It Is Judged
Downstaging does not mean the tumour has vanished from the scan. It means enough has changed that removing all of it has become realistic. Several findings are weighed together, never one alone.
Vessel contact
How much the tumour still touches
The pancreatic-protocol CT is read specifically for the tumour’s relationship to the artery and the vein behind the pancreas. Less contact, or contact a surgeon can reconstruct, is what changes the answer.
The scan overstates it
Treated tissue looks like tumour
After treatment, scar and dead tissue sit where the tumour was and look similar on CT. A scan that appears unchanged does not mean nothing has happened, which is exactly why imaging is never read alone.
Marker trend
Which way CA 19-9 is moving
The direction across successive tests matters far more than any single reading. A marker falling steadily during treatment is one of the more useful signs that the plan is working.
Nothing new
No disease has appeared elsewhere
Restaging looks at the liver and the lining of the abdomen as carefully as it looks at the pancreas. A new deposit changes the plan completely, whatever the main tumour has done.
Your fitness
Whether you could get through it
Weight, muscle, nutrition and how you have coped with treatment all count. Enzyme (PERT) and nutrition support runs alongside chemotherapy at CION for exactly this reason.
One decision
All of it, taken to tumour board
Scans, marker trend, pathology and general health are discussed together by medical oncology, radiation oncology and the surgical partners, rather than settled by one doctor in a corridor.
Take this to your appointment
Questions Worth Asking Before the First Cycle
Written down, in the order they are most useful. None of them is a difficult question to ask, and all of them should have a plain answer.
- Which resectability category am I in? Ask for the word — resectable, borderline, locally advanced — not only the stage. It is the answer that decides the order of everything else.
- What will you reassess, and when? A restaging point agreed in advance turns an open-ended course of treatment into a plan with a decision built into it.
- Who decides whether I get an operation? It should be a tumour board, not one person. At CION the operation itself is performed by partner hepatobiliary surgeons — what a Whipple procedure involves is worth reading before you consent to anything.
- What happens to my jaundice while I am on treatment? If the bile duct is blocked, a stent is usually placed first. That is done by endoscopy partners, and it needs arranging before cycles begin rather than during them.
- Should genetic testing happen now rather than later? An inherited change found early can open up maintenance options afterwards and matters for your family. Genetic counselling is in-house at CION.
- What will this cost, and what is covered? Ask for an estimate in writing, and ask which parts are billed at a partner hospital. Pancreatic cancer treatment in Hyderabad sets out the pathway, and Aarogyasri, NTR Vaidya Seva and insurance cover are checked for you at the first visit.
Bring the scan report and, if you have it, the pathology report. Those two documents settle most of what you want to know about the order of your treatment. Book a free consultation or call 1800 202 8726.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Chemotherapy First Is a Plan, Not a Postponement
Systemic treatment, radiation, nutrition and follow-up are delivered by CION across 35+ centres. The operation is coordinated with partner specialists.
What actually happens
How a Course of Treatment Before Surgery Runs
-
Confirm what the tumour is, on tissue
Chemotherapy is not started on a scan alone. A sample is taken, usually by endoscopic ultrasound with a fine needle, and the pathology report decides which pathway you are on.
Biopsy coordinated with specialist endoscopy partners -
Settle the jaundice, if it is there
A blocked bile duct is usually relieved with a stent at ERCP before treatment begins, because liver function has to be adequate for chemotherapy to be given safely.
ERCP and stenting coordinated with partner centres -
Baseline everything that will be tracked
A pancreatic-protocol contrast CT, CA 19-9, routine bloods, weight and nutritional status are all recorded at the outset, so the change over the coming months can actually be measured.
Ordered and reported in-house at CION -
Give the treatment, and manage it properly
Cycles are delivered at a CION day-care unit close to home, across 35+ centres. Anti-sickness cover, pancreatic enzyme and nutrition support, pain relief and psycho-oncology run alongside, because finishing the course matters as much as starting it.
Chemotherapy delivered in-house at CION -
Restage, then take it back to tumour board
A fresh scan, the marker trend and how you have actually coped are reviewed together by medical oncology, radiation oncology and the surgical partners at the agreed reassessment point.
Tumour board at CION -
Hand over for the operation, or change the plan
If the answer is surgery, you are referred to the partner hepatobiliary team who will operate, and we stay with you through it. If it is not, chemoradiation or SBRT may be added, or systemic treatment continued — pancreatic cancer treatment in Hyderabad sets out every option.
Surgery coordinated with partner HPB surgeons
Plainly stated
What CION Delivers, and What Is Coordinated
Being clear about this early saves a difficult conversation later. Your first consultation is free and lasts 45 minutes, and it is a proper review of your reports rather than a booking appointment. Bring the scan and the pathology report, and we will tell you which category you are in and why the order has been proposed the way it has.
Delivered in-house at CION, across 35+ centres in Telangana and Andhra Pradesh: chemotherapy before surgery, after surgery and for advanced disease; PARP-inhibitor-class maintenance where an inherited BRCA change is found; immune checkpoint inhibitor therapy where the tumour is mismatch-repair deficient; and systemic treatment for neuroendocrine tumours. Also radiation, chemoradiation and SBRT; tumour-board planning and the resectability decision; the ordering and reporting of pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods; genetic counselling; nutrition and pancreatic enzyme replacement; pain relief, psycho-oncology and supportive care; and survivorship follow-up.
Coordinated with specialist hepatobiliary, gastroenterology and endoscopy partner centres, and may be billed there: all pancreatic surgery, including the Whipple procedure and distal pancreatectomy; endoscopic ultrasound with biopsy; ERCP and biliary or duodenal stenting; staging laparoscopy; coeliac plexus block for pain; PET-CT and DOTATATE PET; and peptide receptor radionuclide therapy. We arrange these, we sit in on the decisions and we tell you in advance where each one happens and who invoices you. We do not describe them as our own theatre or endoscopy lists, because they are not.
Said plainly
What Happens If the Tumour Does Not Shrink
Not every course of treatment ends with an operation, and you should hear that before you start rather than at the restaging appointment. Some tumours stay exactly where they are. A few grow, or a deposit appears in the liver during those months. It is a hard thing to be told, and pretending otherwise would not help you.
What is worth understanding is that this is less the treatment failing than the cancer showing what it is. A tumour that spreads within a few months of diagnosis was already spreading on the day of the scan, before anything was given. An operation at that point would have removed the visible disease and left the rest, at the cost of a long recovery. Finding that out during treatment rather than after surgery is a genuinely better outcome, even though it does not feel like one.
The plan then changes rather than stops. Chemoradiation or SBRT may be added where the disease is still confined to the pancreas and the surrounding vessels, and both are delivered in-house at CION. Systemic treatment may switch to a different class. Where pain is the dominant problem, a coeliac plexus block is arranged with partner centres, and enzyme replacement, nutrition and psycho-oncology support carry on throughout. The operation question is not closed permanently either — a tumour that stays stable for a long period is sometimes brought back to tumour board.
And when treatment does work, the handover is straightforward: a fresh scan, a tumour-board decision, and a referral to the partner surgical team, with your medical oncologist staying involved through the operation and the chemotherapy that usually follows it.
If you have been told chemotherapy comes first and nobody has explained what happens after it, bring your reports in and we will walk through the whole sequence with you. Book a free consultation or call 1800 202 8726.
Take the next step
Understand the Order Before You Agree to It
We will explain what treating first is aiming at, and exactly when the operation question gets asked again. We walk this journey with you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Chemotherapy before pancreatic surgery — your questions answered
What does neoadjuvant chemotherapy mean in pancreatic cancer?
Neoadjuvant simply means treatment given before an operation rather than after it. In pancreatic cancer it usually means a course of combination chemotherapy delivered over several cycles, followed by a fresh scan and a fresh decision about surgery. It is doing three jobs at once. It works on the tumour itself, aiming to loosen its grip on the blood vessels behind the pancreas so that a surgeon can remove all of it. It works on the disease you cannot see, because pancreatic cancer sheds cells early and those hidden deposits are what usually bring the cancer back after an operation. And it buys time, which shows how this particular cancer behaves before anyone commits to a very large procedure.
Why give chemotherapy before surgery rather than afterwards?
There are two practical reasons. The first is that many people struggle to complete chemotherapy after a pancreatic operation. Recovery is long, appetite and weight take months to return, and treatment often gets delayed or cut short. Given first, it is far more likely to be delivered in full and at full intensity. The second reason is selection. If the cancer spreads during those months, an operation would not have cured it, and you are spared a major procedure and a long recovery for no benefit. NCCN guidance names treatment first as the preferred approach for borderline resectable disease, and as a reasonable option for removable tumours that carry high-risk features.
What does downstaging actually mean?
Downstaging means enough has changed that removing all of the tumour has become realistic when it was not before. It does not mean the tumour has disappeared from the scan, and it is not judged on the scan alone. Several things are weighed together: how much the tumour still touches the artery and the vein behind the pancreas, which way CA 19-9 has moved across successive tests, whether anything new has appeared in the liver or the lining of the abdomen, and whether you are fit enough for the operation being considered. All of it goes to a tumour board rather than being settled by one doctor. Guidance specifically warns that scans taken after treatment tend to overstate how much tumour is left, because scar and dead tissue look much like living tumour.
How long does treatment go on before surgery is reconsidered?
It is set as a number of cycles rather than a number of weeks, and the reassessment point is agreed at the start so the course is not open-ended. In practice most people have a few months of treatment before the restaging scan. The exact length depends on the class of chemotherapy chosen, how well you are tolerating it, and what the marker is doing. Ask for the reassessment point in writing at the first consultation. If side effects are making the course difficult, the intensity can often be adjusted rather than the treatment abandoned, and that conversation should happen early rather than after a cycle has already been missed.
What if the tumour grows while I am on chemotherapy?
It happens, and it is worth knowing in advance that it might. If new disease appears or the tumour clearly progresses, an operation comes off the table for the time being, because removing the visible tumour would leave the rest behind and cost you a long recovery for nothing. The plan changes rather than stops. Chemoradiation or focused radiation may be added where the disease is still confined to the pancreas and the nearby vessels, both delivered in-house at CION. A different class of systemic treatment may be tried. Pain relief, nutrition, enzyme replacement and psycho-oncology support continue throughout, and a tumour that later settles can be brought back to tumour board.
Does chemotherapy first make the operation harder or more dangerous?
Surgeons do describe treated tissue as firmer and more scarred, which can make the dissection around the vessels more demanding. That is one reason the operation belongs with a specialist hepatobiliary team doing it regularly, and at CION it is coordinated with partner surgeons rather than done in-house. It is not a reason to avoid treating first. The benefit of clearing the margin properly, and of knowing the cancer has not already spread, outweighs the added technical difficulty in the situations where guidance recommends this order. What matters far more to your own risk is nutrition, weight and general fitness at the time of surgery, which is why enzyme and nutrition support runs alongside treatment instead of waiting until afterwards.
Will I still need chemotherapy after the operation?
Usually yes, in some form. The total amount of systemic treatment planned for a curative attempt is generally split across the two sides of the operation rather than given only before it, and what you receive afterwards depends on what the pathology report shows and how well you recover. Some people complete the remainder of the same class of treatment. Others switch, or have a gentler course if recovery has been slow. The plan is settled after surgery, not before it, once the removed tissue has been examined properly. This is one reason your medical oncologist stays involved through the operation rather than handing you over and stepping back.
What does CION do, and what happens at the first visit?
The first consultation is free and lasts 45 minutes. We read your scan and pathology reports with you, say plainly which resectability category you are in, and explain what treating first would be aiming at in your situation. Chemotherapy, radiation, chemoradiation and SBRT, imaging and CA 19-9 ordering and reporting, tumour-board planning, genetic counselling, nutrition and pancreatic enzyme support, pain relief and psycho-oncology are delivered by CION across 35+ centres. Pancreatic surgery, endoscopic ultrasound and biopsy, ERCP and stenting, staging laparoscopy and coeliac plexus block are coordinated with specialist partner centres and may be billed there. We check Aarogyasri, NTR Vaidya Seva and insurance cover at that visit, and give you a written estimate.
Medical disclaimer: This page explains why chemotherapy is often given before pancreatic surgery and how downstaging is assessed, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a treatment recommendation; whether treatment before surgery is right for you depends on your own imaging, pathology and fitness, and must be decided with your treating team. Chemotherapy, radiation, chemoradiation and SBRT, imaging and CA 19-9 ordering and reporting, tumour-board planning, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain relief, psycho-oncology and survivorship care are delivered by CION. All pancreatic surgery, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, and peptide receptor radionuclide therapy are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.